SCENE / THE PUBLISHER
About Script NAD
An independent editorial reading of the NAD+ literature — one cold light on the studies, and nothing else behind it.
What this site is
Script NAD is an independent editorial project that publishes summaries of the peer-reviewed research literature on NAD+ and its precursors (NMN, NR, nicotinamide). We read the studies and report what they measured, in plain language, scene by scene. We are not a clinic. We do not employ clinicians, and we do not provide medical advice. We do not manufacture, sell, or distribute any product, and nothing on this site is for sale. Our work is editorial commentary on publicly available science.
What 'Script NAD' means
The name reads "script" as a screenplay — a shot list of the NAD+ literature, each study lit and indexed like a scene — not as a prescription pad. The cinematic framing is a method of reading, not a claim about services. We do not prescribe, we do not run a telehealth pathway, and we do not imply that an "approved NAD+ drug" exists to be prescribed: NAD+ is not FDA-approved for any disease, and most oral products are precursors sold as dietary supplements. The light in the design falls on the data; there is no clinic behind it.
How we handle the evidence
We hold a few lines firmly. Every quantitative claim on the site cites a specific study, listed on the references and citations page. We keep the distinction between NAD+ and its precursors exact — an oral NMN or NR trial is never described as "taking NAD+." We separate human findings from rodent findings explicitly, because the strongest anti-aging data remain in animals while human outcome data stay limited. And we mark the genuine cautions plainly: the compounded, unapproved status of IV NAD+, the FDA Class I endotoxin recall of a compounded injection, and the unsettled marketplace dispute over NMN's supplement status. We describe; we do not recommend.
What we are not
We are not a healthcare provider, a pharmacy, a compounding facility, or a supplement vendor. We do not offer treatment, consultation, prescriptions, or dosing instructions, and no content here should be read as any of those. NAD+ research is active and evolving; our role is to track the published record accurately and present it for general readers and researchers, not to advise anyone on what to do.